Evidence map›Paper›PMID 35157111›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2022

[Update on ablation of ventricular tachyarrhythmias].

Shibu Mathew, Patrick Müller, Carina Hardy, Mauricio Ibrahim Scanavacca, Thomas Deneke

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Unstoppable innovations in electrophysiology].Herzschrittmachertherapie & Elektrophysiologie · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shibu MathewMed. Klinik, Kardiologie, Universitätsklinik Gießen, Gießen, Deutschland.
Patrick MüllerHerz- und Gefäßklinik, Klinikum Vest, Recklinghausen, Deutschland. mueller.patr@googlemail.com.
Carina HardyArrhythmia Unit, Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brasilien.
Mauricio Ibrahim ScanavaccaArrhythmia Unit, Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brasilien.
Thomas DenekeHerz- und Gefäßklinik, Bad Neustadt a.d. Saale, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catheter ablation of ventricular tachycardia (VT) is performed with increasing frequency in clinical practice. Whereas the reported success rates of idiopathic VT are high, catheter ablation of VT in patients with structural heart disease with its scar-related re-entry mechanism may remain a challenge especially if deep intramyocardial or epicardial portions exist. The integration of modern cardiac imaging, new functional mapping strategies and catheter technologies allow optimized identification and characterization of the critical arrhythmogenic substrate and hence a more targeted VT ablation. The extent to which these innovations will have the potential to improve VT ablation success rates will be determined by future studies.

Indexed as

Catheter AblationTachycardia, VentricularArrhythmias, CardiacCicatrixHumansTreatment OutcomeCardiac imaging integrationCatheter ablationDecrement-evoked potential mappingIsochronal late activation mapsVentricular tachycardia

Identifiers

PMID35157111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.